title: The year in atherothrombosis.
authors.affiliation: Zena and Michael A. Wiener Cardiovascular Institute/Marie-Josee and Henry R. Kravis Center for Cardiovascular Health, Mount Sinai School of Medicine, New York, New York, USA.
authors.forename: Javier
authors.initials: J
authors.lastname: Sanz
authors.forename: Valentin
authors.initials: V
authors.lastname: Fuster
mesh_terms: D055109:Ankle Brachial Index; D019440:Anti-Obesity Agents / Q000627:therapeutic use; D001161:Arteriosclerosis / Q000150:complications* / Q000175:diagnosis / Q000628:therapy; D015415:Biomarkers / Q000097:blood; D002097:C-Reactive Protein / Q000032:analysis; D002114:Calcinosis / Q000473:pathology; D003327:Coronary Disease / Q000628:therapy; D003920:Diabetes Mellitus / Q000453:epidemiology / Q000628:therapy; D003952:Diagnostic Imaging; D050171:Dyslipidemias / Q000188:drug therapy; D004691:Endarterectomy; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D005819:Genetic Markers; D006442:Glycated Hemoglobin / Q000032:analysis; D015438:Health Behavior; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D007249:Inflammation / Q000150:complications; D008019:Life Style; D008055:Lipids / Q000097:blood; D024821:Metabolic Syndrome / Q000453:epidemiology; D020097:Natriuretic Peptide, Brain / Q000097:blood; D009765:Obesity / Q000150:complications / Q000188:drug therapy; D018570:Risk Assessment; D012307:Risk Factors; D016540:Smoking Cessation; D015607:Stents; D020521:Stroke / Q000209:etiology / Q000517:prevention & control; D013927:Thrombosis / Q000209:etiology* / Q000517:prevention & control; D019210:Troponin I / Q000097:blood
chemical_list: D019440:Anti-Obesity Agents; D015415:Biomarkers; D002097:C-Reactive Protein; D005343:Fibrinolytic Agents; D005819:Genetic Markers; D006442:Glycated Hemoglobin; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008055:Lipids; D020097:Natriuretic Peptide, Brain; D019210:Troponin I; C517652:hemoglobin A1c protein, human